Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitexceleron.com
Twitter@Xceleron
CategoryAnalytics/Big Data
Phone+44 (0)1904 561 561
Employees
Founded1997
DescriptionIn administration (Chapter 11)

Offices

HQ
20340 Seneca Meadows Parkway
Germantown, MD, 20876
GBR

People

CEO & Board Of director
Vice President of Operations
Board of Directors
Board of Directors
Director of Science and Technology
CFO & Board Of director

Funding

TOTAL $6.05M
FUNDING TOTAL $6.05M
Venture Round, 5/2005
Close Venture Management
Foursome Investments
£2M
Venture Round, 1/2010
Albion Investors
Frog Capital
Venture Round, 2/2012
Albion Ventures
Solon Ventures
$2.4M

Tags

Xceleron (Chapter 11)

Xceleron Ltd entered administration (chapter 11) on January 10th 2012 with debts of £7m. It provided bioanalytical accelerator mass spectrometry (AMS) services for drug development. It conducted microdosing, pre-clinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. The company served the pharmaceutical and biotechnology markets. Xceleron Ltd was formerly known as The Centre for Biomedical Accelerator Mass Spectrometry Ltd. and changed its name to Xceleron Ltd in 2003. The company was founded in 1997 and was headquartered in York, the United Kingdom with a facility in Maryland.

Recent Milestones

Videos

Screenshots

Xceleron (Chapter 11) screenshot
Above: Home Page
Uploaded: 1/22/10

Sources

  1. Spin-out backing strengthens University of York business links (york.ac.uk) [edit]
  2. Xceleron Looks To Accelerate Drug Research With Fresh Funds (fis.dowjones.com) [edit]
  3. Xceleron Raises $2.4M in Funding (finsmes.com) [edit]
  4. Companies House (wck2.companieshouse.gov.uk) [edit]
Edit This Page
Last Edited 5/2/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy